Correlation Between Tscan Therapeutics and Legato Merger
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Legato Merger at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Legato Merger into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Legato Merger II, you can compare the effects of market volatilities on Tscan Therapeutics and Legato Merger and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Legato Merger. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Legato Merger.
Diversification Opportunities for Tscan Therapeutics and Legato Merger
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tscan and Legato is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Legato Merger II in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Legato Merger II and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Legato Merger. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Legato Merger II has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Legato Merger go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Legato Merger
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 1.05 times more return on investment than Legato Merger. However, Tscan Therapeutics is 1.05 times more volatile than Legato Merger II. It trades about -0.01 of its potential returns per unit of risk. Legato Merger II is currently generating about -0.03 per unit of risk. If you would invest 648.00 in Tscan Therapeutics on August 27, 2024 and sell it today you would lose (222.00) from holding Tscan Therapeutics or give up 34.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. Legato Merger II
Performance |
| Timeline |
| Tscan Therapeutics |
| Legato Merger II |
Tscan Therapeutics and Legato Merger Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Legato Merger
The main advantage of trading using opposite Tscan Therapeutics and Legato Merger positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Legato Merger can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legato Merger will offset losses from the drop in Legato Merger's long position.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
| Legato Merger vs. Sellas Life Sciences | Legato Merger vs. Apogee Therapeutics, Common | Legato Merger vs. Tscan Therapeutics | Legato Merger vs. Bright Scholar Education |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |